F 
1,956
+0.31%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in JPY, from our data supplier.
Revenue
¥6.80bn
FY2017FY2026
Net income
¥63.6m
FY2017FY2026
Free cash flow
¥272.2m
FY2017FY2026
Shareholders' equity
¥4.05bn
FY2017FY2026
Income statement
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ¥6.80bn | ¥7.20bn | ¥7.51bn | ¥8.09bn | ¥8.15bn | ¥6.85bn | ¥7.21bn | ¥8.34bn | ¥7.93bn | ¥7.23bn |
| Gross profit | ¥1.76bn | ¥1.53bn | ¥1.80bn | ¥2.02bn | ¥1.82bn | ¥1.54bn | ¥1.44bn | ¥2.44bn | ¥2.00bn | ¥1.88bn |
| Research and development | — | ¥172.8m | ¥194.0m | ¥195.0m | ¥206.0m | ¥211.0m | ¥261.0m | — | ¥275.0m | ¥231.0m |
| Operating income | ¥415.8m | ¥255.5m | ¥439.7m | ¥760.9m | ¥529.2m | ¥269.3m | ¥35.0m | ¥610.5m | ¥648.0m | ¥549.3m |
| Net income | ¥63.6m | ¥298.2m | ¥289.7m | ¥517.3m | −¥142.8m | ¥170.1m | −¥26.0m | ¥397.8m | ¥91.8m | ¥392.5m |
| Diluted earnings per share | 50.21 | 235.23 | 228.49 | 407.94 | -112.61 | 134.08 | -20.48 | 313.33 | 72.01 | 310.25 |
Balance sheet
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | ¥10.27bn | ¥11.12bn | ¥11.41bn | ¥11.54bn | ¥11.85bn | ¥12.48bn | ¥12.69bn | ¥13.57bn | ¥10.58bn | ¥9.51bn |
| Cash and short-term investments | ¥2.27bn | ¥2.34bn | ¥1.70bn | ¥1.94bn | ¥1.91bn | ¥1.65bn | ¥1.50bn | ¥1.90bn | ¥1.58bn | ¥1.60bn |
| Total liabilities | ¥6.22bn | ¥7.05bn | ¥7.55bn | ¥7.96bn | ¥8.76bn | ¥9.17bn | ¥9.58bn | ¥10.33bn | ¥7.65bn | ¥6.65bn |
| Debt | ¥5.05bn | ¥5.31bn | ¥5.50bn | ¥5.76bn | ¥6.37bn | ¥7.27bn | ¥7.62bn | ¥7.71bn | ¥5.12bn | ¥4.60bn |
| Shareholders' equity | ¥4.05bn | ¥4.07bn | ¥3.86bn | ¥3.58bn | ¥3.10bn | ¥3.30bn | ¥3.12bn | ¥3.24bn | ¥2.93bn | ¥2.86bn |
| Shares outstanding | 1m | 1m | 1m | 1m | 1m | 1m | 1m | 1m | 1m | 1m |
Cash flow
Fiscal years
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ¥613.7m | ¥633.6m | ¥211.0m | ¥771.6m | ¥1.19bn | ¥705.6m | ¥439.0m | ¥291.0m | ¥858.0m | ¥303.0m |
| Capital spending | −¥341.5m | −¥168.2m | −¥116.4m | −¥70.4m | −¥136.7m | −¥106.3m | −¥507.0m | −¥2.02bn | −¥1.34bn | −¥1.01bn |
| Free cash flow | ¥272.2m | ¥465.4m | ¥94.6m | ¥701.3m | ¥1.05bn | ¥599.4m | −¥68.0m | −¥1.72bn | −¥481.0m | −¥703.0m |
| Dividends paid | −¥98.4m | −¥63.7m | −¥63.0m | −¥63.5m | −¥63.3m | −¥37.8m | −¥63.5m | −¥63.0m | −¥63.0m | −¥63.0m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ¥1.81bn | ¥1.68bn | ¥1.69bn | ¥1.70bn | ¥1.73bn | ¥1.70bn | ¥1.86bn | ¥1.83bn |
| Gross profit | ¥461.3m | ¥395.6m | ¥448.1m | ¥430.1m | ¥491.1m | ¥359.5m | ¥382.0m | ¥358.7m |
| Operating income | ¥117.8m | ¥55.0m | ¥112.3m | ¥85.2m | ¥163.2m | ¥16.8m | ¥57.0m | ¥40.2m |
| Net income | ¥142.4m | −¥31.6m | ¥57.7m | ¥42.5m | −¥5.0m | ¥200.7m | ¥39.0m | −¥13.8m |
| Diluted earnings per share | 112.38 | -24.96 | 45.55 | 33.56 | -3.95 | 158.38 | 30.76 | -10.89 |
| Total assets | ¥10.50bn | ¥10.27bn | ¥10.84bn | ¥10.36bn | ¥11.26bn | ¥11.12bn | ¥11.15bn | ¥11.17bn |
| Cash and short-term investments | ¥2.59bn | ¥2.27bn | ¥2.22bn | ¥1.58bn | ¥2.36bn | ¥2.34bn | ¥1.98bn | ¥1.87bn |
| Debt | ¥3.56bn | ¥4.95bn | ¥3.56bn | ¥4.71bn | ¥3.39bn | ¥5.16bn | ¥3.30bn | ¥5.17bn |
| Shareholders' equity | ¥4.09bn | ¥4.05bn | ¥4.07bn | ¥4.01bn | ¥3.96bn | ¥4.07bn | ¥3.84bn | ¥3.81bn |
Financial ratios
Data as of 26 Oct 2026
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 26.0% | 21.2% | 23.9% | 25.0% | 22.4% | 22.4% | — |
| Operating margin | 6.1% | 6.2% | 5.7% | 9.7% | 0.0% | 4.5% | — |
| Net margin | 0.9% | 4.1% | 3.9% | 6.4% | -1.8% | 2.5% | — |
| Return on equity | 1.6% | 7.3% | 7.5% | 14.5% | -4.6% | 5.1% | — |
| Return on assets | 0.6% | 2.7% | 2.5% | 4.5% | -1.2% | 1.4% | — |
| Free cash flow yield | 37.9% | 31.9% | 13.0% | 33.4% | 52.7% | 32.2% | — |
| Revenue growth | -5.6% | -4.1% | -7.1% | -0.8% | 18.9% | -5.0% | — |
| Earnings growth | -78.7% | 2.9% | -44.0% | -462.3% | -183.9% | -754.2% | — |
| Current ratio | 1.26x | 1.34x | 1.31x | 1.24x | 1.11x | 1.06x | — |
| Debt to equity | 1.22x | 1.27x | 1.36x | 1.51x | 1.91x | 2.02x | — |
| Equity ratio | 39.4% | 36.6% | 33.8% | 31.0% | 26.1% | 26.5% | — |
| Interest coverage | 5.39x | 6.78x | 8.15x | 13.31x | 0.06x | 4.15x | — |
| R&D as a share of sales | — | 2.4% | 2.6% | 2.4% | 2.5% | 3.1% | 3.6% |
| Buybacks as a share of market value | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | -5.6% | -0.2% | -0.2% |
| Operating income | -18.2% | 9.1% | -4.4% |
| Net income | -50.3% | -17.9% | -16.9% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 23.5% | 24.0% | 23.5% | 24.5% |
| Operating margin | 4.8% | 6.3% | 6.0% | 6.3% |
| Net margin | 2.6% | 3.9% | 2.7% | 3.0% |
Valuation history
At each fiscal year end
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 38.8 | 8.3 | 7.3 | 4.6 | -16.6 | 14.8 | -156.2 | 6.4 | 27.4 | 9.5 |
| Price to sales | 0.4 | 0.3 | 0.3 | 0.3 | 0.3 | 0.4 | 0.6 | 0.3 | 0.3 | 0.5 |
Dividends and splits
Per share, in the currency the company pays
Paid for 10 years. Last went ex-dividend on 30 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 158.00 | 50.00 | 50.00 | 50.00 | 50.00 | 30.00 | 50.00 | 50.00 |
- 10-to-1 reverse split · 27 Sept 2017
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.